Aristotle Capital Boston’s Envision Healthcare Holdings Inc EVHC Stock Holding History

Aristotle Capital Boston’s Portfolio EVHC Stock Details EVHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-419,152	Closed	-$19.2M	–	123
2018 Q3	$19.2M	Buy	419,152 +32,569	+8%	+$1.46M	1.41%	18
2018 Q2	$17M	Sell	386,583 -230,206	-37%	-$9.46M	1.35%	15
2018 Q1	$23.7M	Buy	616,789 +235,728	+62%	+$8.81M	1.11%	29
2017 Q4	$13.2M	Buy	381,061 +82,170	+27%	+$2.87M	0.96%	39
2017 Q3	$13.4M	Buy	298,891 +59,962	+25%	+$3.2M	1.2%	21
2017 Q2	$15M	Buy	238,929 +49,018	+26%	+$2.82M	1.67%	10
2017 Q1	$11.6M	Buy	189,911 +5,625	+3%	+$377K	1.55%	14
2016 Q4	$11.7M	Buy	+184,286	New	+$12M	1.6%	11

Other funds holding EVHC

SEI Investments Oaks, Pennsylvania $108B AUM 26.14% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $830M AUM 21.8% 1-Year Est. Return

Aristotle Capital Boston's EVHC Position: Q4 2018 in Review

Aristotle Capital Boston sold out of Envision Healthcare Holdings Inc (EVHC) in Q4 2018, closing a stake of 419,152 shares — an estimated $19.2M sold.

Aristotle Capital Boston first reported a position in EVHC in Q4 2016 and held it in 8 quarters. The position peaked at $23.7M in Q1 2018. 4 funds tracked by Wall St. Rank hold EVHC as of Q4 2018.

Aristotle Capital Boston reported no remaining Envision Healthcare Holdings Inc position as of Q4 2018 after selling out during the quarter.
Aristotle Capital Boston sold 419,152 Envision Healthcare Holdings Inc shares in Q4 2018, an estimated $19.2M.
Aristotle Capital Boston first reported a position in Envision Healthcare Holdings Inc in Q4 2016 and held it in 8 quarters.
Aristotle Capital Boston's Envision Healthcare Holdings Inc position peaked at $23.7M in Q1 2018.
4 funds tracked by Wall St. Rank held Envision Healthcare Holdings Inc as of Q4 2018.

Based on Aristotle Capital Boston's 13F filing for Q4 2018, filed 13 Feb 2019.